Gaush Meditech Ltd. (HK:2407) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Gaush Meditech Ltd has released a profit update indicating a significant drop in net profit for the first half of 2024, with an expected decrease of approximately 74.5% to 76.8% compared to the same period last year. The decline is attributed to reduced revenue post-pandemic, changes in domestic medical service policies, and increased R&D expenditures. Despite the downturn, the company remains optimistic about the second half of 2024 due to policy changes in national procurement for intraocular lenses.
For further insights into HK:2407 stock, check out TipRanks’ Stock Analysis page.